Experimental Targeted Therapy Using [211At]meta-Astatobenzylguanidine and Transfection of the Noradrenaline Transporter Gene

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|1|3|197-202

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.1, Iss.3, 2008-09, pp. : 197-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Evaluation of no-Carrier-Added [131I]Meta-Iodobenzyl Guanidine, for the Treatment of Tumours Transfected with the Noradrenaline Transporter Gene

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 1, 2004-01 ,pp. : 50-57

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy and Targeted Toxins for Glioma

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 535-557

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Gene Therapy for Ovarian Cancer

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 643-653

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy and Targeted Toxins for Glioma

By  

Current Gene Therapy, Vol. 11, Iss. 3, 2011-06 ,pp. : 155-180

Bentham Science Publishers

Access to resources Recommend Favorite

Cationic Transfection Lipids in Gene Therapy: Successes, Set-backs, Challenges and Promises

By  

Current Medicinal Chemistry, Vol. 10, Iss. 14, 2003-07 ,pp. : 1297-1306

Bentham Science Publishers

Access to resources Recommend Favorite